1. Before approval of the coflex device, fusion was the only option for stabilization after decompression for the treatment of lumbar spinal stenosis, which is expensive, said Dr. Chappuis. Spinal fusions are also associated with loss of movement, longer recovery times and dependency on narcotics to relieve postoperative pain.
2. In a Level 1 prospective, randomized controlled trial, Paradigm Spine proved the coflex device outperformed fusion in all clinical outcome measurements at two years.
3. In addition to clinical benefits, the coflex device and procedure has cost-effectiveness data supporting its use. An analysis of Medicare data shows the potential cost-savings of more than $13,000 in the first year after the procedure and over $14,500 in the second year compared to traditional fusion.
4. A study, published in March 2014 in the Journal of ClinicoEconomics and Outcomes Research, showed the coflex device significantly reduced healthcare costs over five years.
5. For trained spinal surgeons, the coflex device is easy to incorporate into a medical practice.
Paradigm Spine is hosting another webinar on September 18, titled “Growing your ASC Spine Practice — A Discussion on Contemporary MIS Technology for Spinal Stenosis.” To register, click here.
More articles on Paradigm Spine:
Medical device industry leader to know: Hector Torres of Paradigm Spine
7 recent study findings on spine, orthopedic devices
WebMD includes U-shaped interlaminar implant as spinal stenosis treatment option
